Research hotspots and trends on potentially inappropriate medication from 2012 to 2021

QIAO Gaoxing; CHU Yaojuan; LIU Chong; WANG Shujuan; LIU Kefeng; DU Shuzhang

doi:10.6039/j.issn.1001-0408.2023.03.22

您当前的位置：

首页 >

文章列表页 >

Research hotspots and trends on potentially inappropriate medication from 2012 to 2021

更新时间：2023-02-22

- Research hotspots and trends on potentially inappropriate medication from 2012 to 2021
- ZHONGGUO YAOFANG Vol. 34, Issue 3, Pages: 370-375(2023)
- 作者机构：
  
  郑州大学第一附属医院药学部，郑州　450002
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.03.22
  CLC： R969.3
- Published：15 February 2023，
  
  Received：27 July 2022，
  
  Revised：27 December 2022，
扫描看全文
乔高星,楚尧娟,刘冲等.2012－2021年潜在不适当用药的研究热点与趋势分析 ^Δ[J].中国药房,2023,34(03):370-375.

QIAO Gaoxing,CHU Yaojuan,LIU Chong,et al.Research hotspots and trends on potentially inappropriate medication from 2012 to 2021[J].ZHONGGUO YAOFANG,2023,34(03):370-375.
乔高星,楚尧娟,刘冲等.2012－2021年潜在不适当用药的研究热点与趋势分析 ^Δ[J].中国药房,2023,34(03):370-375. DOI： 10.6039/j.issn.1001-0408.2023.03.22.

QIAO Gaoxing,CHU Yaojuan,LIU Chong,et al.Research hotspots and trends on potentially inappropriate medication from 2012 to 2021[J].ZHONGGUO YAOFANG,2023,34(03):370-375. DOI： 10.6039/j.issn.1001-0408.2023.03.22.

摘要

目的

通过文献计量学的方法，定量和定性分析潜在不适当用药（PIM）研究的进展，并预测PIM研究的热点和趋势，为我国开展PIM研究提供参考。

方法

检索Web of Science核心数据库与PIM相关的研究文献，在文献计量在线分析平台和CiteSpace 5.8.R3软件上分析文献的发表趋势，并对研究结果进行可视化分析，通过gCLUTO软件总结PIM的研究热点。

结果

关于PIM的研究，2012－2021年的年发文量整体呈持续增长的趋势；美国的发文量最多（241篇）；澳大利亚悉尼大学为发文量最多（59篇）的研究机构；来自爱尔兰科克大学的O’Mahony D教授发文量最多（23篇）；PIM的研究涉及57个学科领域，其中老年学发文量最多（384篇）；期刊

International Journal of Clinical Pharmacy

的发文量最多（61篇）；期刊

Journal of the American Geriatrics Society

的总被引频次最高（1 197次）。PIM的研究热点主要集中在PIM的标准研究、PIM的安全性与经济性研究、PIM的风险因素研究、慢病患者的PIM研究、抗精神病药物的PIM研究、药师参与PIM管理的研究、肿瘤姑息治疗中的PIM研究7个方面。

结论

PIM研究的热度一直在上升，国家与机构间合作不紧密，需要增进合作。未来我国药师关于PIM的研究重点可能在PIM标准的深度本土化、PIM的干预与精准用药指导、专病专药的PIM管理等方面。

Abstract

OBJECTIVE

To quantitatively and qualitatively analyze the progress of potentially inappropriate medication （PIM） research by means of bibliometrics， and to predict the hotspots and trends of PIM， so as to provide reference for PIM research in China.

METHODS

The research literature related to PIM were searched from Web of Science core database， and the publication trend of the literature was analyzed on the bibliometric online analysis platform and CiteSpace 5.8.R3 software. The research results were visualized and analyzed， and the research hotspots of PIM were summarized through gCLUTO.

RESULTS

About PIM research， the annual number of the literature issued from 2012 to 2021 showed a continuous growth trend totally； the United States had the largest number of literature （241 pieces）； the University of Sydney in Australia was the research institution with the largest number of literature （59 pieces）； O’Mahony D from University College Cork， Ireland， published the most literature （23 pieces）； the research of PIM involved 57 disciplines， among which there was the largest number of literature about gerontology （384 pieces）；

International Journal of Clinical Pharmacy

was the journal with the largest number of literature （61 pieces）；

Journal of the American Geriatrics Society

was cited most frequently （1 197 times）. The hotspots of PIM research mainly focused on seven aspects： the standard of PIM， the safety and economy research of PIM， the risk factors research of PIM， the PIM research of chronic patients， the PIM research of antipsychotics， the research of pharmacists’ participation in PIM management， and the PIM research about palliative care of tumor patients.

CONCLUSIONS

The heat of research on PIM has been on the rise， and there is little cooperation between countries and institutions， and more cooperation is needed. In the future， the focus of Chinese pharmacists’ research on PIM may be on the deep localization of PIM standards， PIM intervention and precise medication guidance， and PIM management of specific diseases and drugs.

关键词

潜在不适当用药用药安全合理用药可视化分析文献计量学研究热点

Keywords

medication safetyrational drug usevisual analysisbibliometricsresearch hotspots

references

BEERS M H，OUSLANDER J G，ROLLINGHER I，et al. Explicit criteria for determining inappropriate medication use in nursing home residents[J]. Arch Intern Med，1991，151（9）：1825-1832.

舒冰，刘玉龙，姜玲.老年人潜在不适当用药评估标准研究进展[J].中国医院药学杂志，2019，39（18）：1905-1910.

FIALOVÁ D，BRKIĆ J，LAFFON B，et al. Applicability of EU（7）-PIM criteria in cross-national studies in European countries[J]. Ther Adv Drug Saf，2019，10：2042-2050.

MA Z，TONG Y L，ZHANG C X，et al. Potentially inappropriate medications and potentially prescribing omissions in Chinese older patients：comparison of two versions of STOPP/START[J]. J Clin Pharm Ther，2020，45（6）：1405-1413.

POHL-DERNICK K，MEIER F，MAAS R，et al. Potentially inappropriate medication in the elderly in Germany：an economic appraisal of the PRISCUS list[J]. BMC Health Serv Res，2016，16：109.

FENG X，HIGA G M，SAFARUDIN F，et al. Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal，breast，and prostate cancers[J]. J Geriatr Oncol，2019，10（5）：698-704.

中国老年保健医学研究会老年合理用药分会，中华医学会老年医学分会，中国药学会老年药学专业委员会，等. 中国老年人潜在不适当用药判断标准：2017年版[J]. 药物不良反应杂志，2018，20（1）：2-8.

唐超. “银发浪潮”呼唤老年医学前行[J].中国医院院长，2021，17（14）：32-40.

凌曦，赵志刚，李新刚.人工智能技术在药学领域的应用：基于Web of Science的文献可视化分析[J]. 中国药房，2019，30（4）：433-438.

耿一睿，苗红，贾菲，等. 基于CiteSpace的旅游研究科研合作网络可视化分析[J]. 旅游研究，2019，11（5）：14-24.

朱光，黄毅.图像语义检索研究热点与前沿的可视化分析[J].情报科学，2013，31（3）：127-131，135.

CHEN C M. CiteSpace Ⅱ：detecting and visualizing emerging trends and transient patterns in scientific literature[J]. J Am Soc Inf Sci Technol，2006，57（3）：359-377.

楚尧娟，陈娟娟，乔高星，等.定量药理学研究文献的可视化分析[J].中国医院药学杂志，2020，40（16）：1714-1719.

By The 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc，2019，67（4）：674-694.

O'MAHONY D，O’SULLIVAN D，BYRNE S，et al. STOPP/START criteria for potentially inappropriate prescribing in older people：version 2[J]. Age Ageing，2015，44（2）：213-218.

RENOM-GUITERAS A，MEYER G，THÜRMANN P A. The EU（7）-PIM list：a list of potentially inappropriate medications for older people consented by experts from seven European countries[J]. Eur J Clin Pharmacol，2015，71（7）：861-875.

HOLT S，SCHMIEDL S，THÜRMANN P A. Potentially inappropriate medications in the elderly：the PRISCUS list[J]. Dtsch Arztebl Int，2010，107（31/32）：543-551.

KUHN-THIEL A M，WEIß C，WEHLING M，et al. Consensus validation of the FORTA （Fit fOR The Aged） List：a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly[J]. Drugs Aging，2014，31（2）：131-140.

KIM S O，JANG S，KIM C M，et al. Consensus validated list of potentially inappropriate medication for the elderly and their prevalence in south Korea[J].Int J Gerontol，2015，9（3）：136-141.

ROGNSTAD S，BREKKE M，FETVEIT A，et al. The Norwegian General Practice （NORGEP） criteria for assessing potentially inappropriate prescriptions to elderly patients[J]. Scand J Prim Health Care，2009，27（3）：153-159.

HANLON J T，SCHMADER K E. The medication appropriateness index at 20：where it started，where it has been，and where it may be going[J]. Drugs Aging，2013，30（11）：893-900.

HEIDER D，MATSCHINGER H，MEID A D，et al. Health service use，costs，and adverse events associated with potentially inappropriate medication in old age in Germany：retrospective matched cohort study[J]. Drugs Aging，2017，34（4）：289-301.

SHEIKH REZAEI S，ŠINKOVEC H，SCHÖBERL A， et al. Utilization of potentially inappropriate medication and risk of adverse drug events among older adults with chronic renal insufficiency：a population-wide cohort study[J]. BMC Geriatr，2021，21（1）：117.

HYTTINEN V，JYRKKÄ J，SAASTAMOINEN L K， et al. The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons：a longitudinal 12-year study[J]. Eur J Health Econ，2019，20（2）：233-243.

HEIDER D，MATSCHINGER H，MEID A D，et al. The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study[J]. PLoS One，2018，13（7）：e0198004.

OKPECHI I G，TINWALA M M，MUNEER S，et al. Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease：protocol for a systematic review and meta-analysis[J]. Syst Rev，2021，10（1）：198.

OKTORA M P，ALFIAN S D，BOS H J，et al. Trends in polypharmacy and potentially inappropriate medication （PIM） in older and middle-aged people treated for diabetes[J]. Br J Clin Pharmacol，2021，87（7）：2807-2817.

ARNOLD I，STRAUBE K，HIMMEL W，et al. High prevalence of prescription of psychotropic drugs for older patients in a general hospital[J]. BMC Pharmacol Toxicol，2017，18（1）：76.

WOLFF J，HEFNER G，NORMANN C，et al. Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry[J]. Pharmacoepidemiol Drug Saf，2021，30（9）：1258-1268.

CHAO C T，TSAI H B，CHIANG C K，et al. Association between education level and potentially inappropriate medication among older patients[J]. Aging Clin Exp Res，2018，30（1）：101-103.

SUN W，TAHSIN F，ABBASS DICK J，et al. Educating homecare nurses about deprescribing of medications to manage polypharmacy for older adults[J]. West J Nurs Res，2021：193945920982599.

KRAUSE O，WIESE B，DOYLE I M，et al. Multidisciplinary intervention to improve medication safety in nur- sing home residents：protocol of a cluster randomised controlled trial （HIOPP-3-iTBX study）[J]. BMC Geriatr，2019，19（1）：24.

BITTER K，PEHE C，KRÜGER M，et al. Pharmacist-led medication reviews for geriatric residents in German long-term care facilities[J]. BMC Geriatr，2019，19（1）：39.

CHOUKROUN C，LEGUELINEL-BLACHE G，ROUX-MARSON C，et al. Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer[J]. J Geriatr Oncol，2021，12（1）：57-63.

VAN MERENDONK L N，CRUL M. Deprescribing in palliative patients with cancer：a concise review of tools and guidelines[J]. Support Care Cancer，2022，30（4）：2933-2943.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

KAP investigation and analysis of drug use safety risk of Sanjin tablets

基于CNKI高被引论文的近20年中药研究热点与发展趋势分析Δ

Bibliometric analysis for research hotspot and frontier of ursolic acid

Review of Drug Safety Crime Research in China （1985-2019）

Related Author

ZHENG Hongmei

ZHAO Ya

MA Jing

WANG Panpan

LING Xiao

LI Chunxiao

YANG Yalei

任永申吕宏宇马艳芹张蓉蓉董旖张萍李燕

Related Institution

Dept. of Pharmacy， the First Affiliated Hospital of Henan University of Chinese Medicine/Henan Provincial Engineering Research Center for Clinical Application， Evaluation and Transformation of Traditional Chinese Medicine/Henan Provincial Traditional Chinese Medicine Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine

Collaborative Innovation Center of TCM Prevention and Treatment of Respiratory Diseases， Henan University of Chinese Medicine

Dept. of Pharmacy， Xinmi Municipal Hospital of Traditional Chinese Medicine， Henan Xinmi

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰